Viral infections in liver transplantation recipients

被引：0

作者：

Ciesek, S. ^{[1
]}

Wedemeyer, H. ^{[2
,3
]}

机构：

[1] Univ Klinikum Frankfurt, Inst Med Virol, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany

[2] Univ Klinikum Frankfurt, Klin Gastroenterol & Hepatol, Essen, Germany

[3] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany

来源：

GASTROENTEROLOGE | 2020年 / 15卷 / 03期

关键词：

Liver transplantation; Hepatitis viruses; Herpesviridae; BK virus; Prevention and control; HEPATITIS-E; BK POLYOMAVIRUS; VIRUS-INFECTION; CYTOMEGALOVIRUS; PROPHYLAXIS; DIAGNOSIS; REACTIVATION; MANAGEMENT; HHV-6;

D O I：

10.1007/s11377-020-00434-x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Liver transplantation has become a standard therapy for patients with advanced liver disease and hepatocellular carcinoma. The long-term outcome after liver transplantation improved due to improvements in surgical techniques, imaging and better immunosuppressive agents. Still, immunosuppression may increase the risk for infections and may alter the course of chronic infections in organ recipients. This article summarizes the current knowledge on viral infection after liver transplantation and therapeutic options.

引用

页码：227 / 234

页数：8

共 31 条

[1] Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients [J].

Arguedas, MR ;

Johnson, A ;

Eloubeidi, MA ;

Fallon, MB .

HEPATOLOGY, 2001, 34 (01) :28-31

[2] The impact of hepatitis E in the liver transplant setting [J].

Behrendt, Patrick ;

Steinmann, Eike ;

Manns, Michael P. ;

Wedemeyer, Heiner .

JOURNAL OF HEPATOLOGY, 2014, 61 (06) :1418-1429

[3] ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients [J].

Belli, Luca S. ;

Duvoux, Christophe ;

Berenguer, Marina ;

Berg, Thomas ;

Coilly, Audrey ;

Colle, Isabelle ;

Fagiuoli, Stefano ;

Khoo, Saye ;

Pageaux, Georges Philippe ;

Puoti, Massimo ;

Samuel, Didier ;

Strazzabosco, Mario .

JOURNAL OF HEPATOLOGY, 2017, 67 (03) :585-602

[4] Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection - The German Guideline [J].

Cornberg, M. ;

Protzer, U. ;

Petersen, J. ;

Wedemeyer, H. ;

Berg, T. ;

Jilg, W. ;

Erhardt, A. ;

Wirth, S. ;

Sarrazin, C. ;

Dollinger, M. M. ;

Schirmacher, P. ;

Dathe, K. ;

Kopp, I. B. ;

Zeuzem, S. ;

Gerlich, W. H. ;

Manns, M. P. .

ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (07) :871-930

[5]

Dalton H, 2018, J HEPATOL, V68, P1256, DOI DOI 10.1016/J.JHEP.2018.03.005

[6] Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta [J].

Deterding, Katja ;

Wedemeyer, Heiner .

AIDS REVIEWS, 2019, 21 (03) :126-134

[7] EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection [J].

Lampertico P. ;

Agarwal K. ;

Berg T. ;

Buti M. ;

Janssen H.L.A. ;

Papatheodoridis G. ;

Zoulim F. ;

Tacke F. .

JOURNAL OF HEPATOLOGY, 2017, 67 (02) :370-398

[8] Cytomegalovirus in transplantation -: challenging the status quo [J].

Fishman, Jay A. ;

Emery, Vincent ;

Freeman, Richard ;

Pascual, Manuel ;

Rostaing, Lionel ;

Schlitt, Hans J. ;

Sgarabotto, Dino ;

Torre-Cisneros, Julian ;

Uknis, Marc E. .

CLINICAL TRANSPLANTATION, 2007, 21 (02) :149-158

[9] Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients [J].

Friebus-Kardash, Justa ;

Gaeckler, Anja ;

Kribben, Andreas ;

Witzke, Oliver ;

Wedemeyer, Heiner ;

Treckmann, Juergen ;

Herzer, Kerstin ;

Eisenberger, Ute .

TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (05)

[10] Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo [J].

Giersch, Katja ;

Bhadra, Oliver D. ;

Volz, Tassilo ;

Allweiss, Lena ;

Riecken, Kristoffer ;

Fehse, Boris ;

Lohse, Ansgar W. ;

Petersen, Joer ;

Sureau, Camille ;

Urban, Stephan ;

Dandri, Maura ;

Luetgehetmann, Marc .

GUT, 2019, 68 (01) :150-157

← 1 2 3 4 →